Jefferies Financial Group’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$908K Buy
107,035
+92,035
+614% +$612K 0.01% 1012
2026
Q1
$81.8K Buy
+15,000
New +$84.2K ﹤0.01% 1619
2024
Q4
– Sell
-10,203
Closed -$93.7K – 1845
2024
Q3
$93.7K Buy
+10,203
New +$84.4K ﹤0.01% 1311
2024
Q1
– Sell
-20,100
Closed -$433K – 2021
2023
Q4
$433K Buy
+20,100
New +$371K ﹤0.01% 1277
2023
Q2
– Sell
-5,401
Closed -$140K – 1999
2023
Q1
$140K Buy
+5,401
New +$145K ﹤0.01% 1398

Other funds holding TDOC

Jefferies Financial Group's TDOC Position: Q2 2026 in Review

Jefferies Financial Group increased its Teladoc Health (TDOC) stake by 614% in Q2 2026, buying an estimated $612K and bringing the position to 107,035 shares worth $908K. The position accounts for 0.01% of the portfolio, ranked #1012.

Jefferies Financial Group first reported a position in TDOC in Q1 2023 and has held it in 5 quarters since. 348 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Jefferies Financial Group held 107,035 shares of Teladoc Health worth $908K as of Q2 2026.
  • Jefferies Financial Group bought 92,035 Teladoc Health shares in Q2 2026, an estimated $612K.
  • Teladoc Health made up 0.01% of Jefferies Financial Group's portfolio in Q2 2026, its #1012 holding.
  • Jefferies Financial Group first reported a position in Teladoc Health in Q1 2023 and has held it in 5 quarters since.
  • 348 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.